148 related articles for article (PubMed ID: 17851694)
1. RAAS gene polymorphisms influence progression of pediatric hypertrophic cardiomyopathy.
Kaufman BD; Auerbach S; Reddy S; Manlhiot C; Deng L; Prakash A; Printz BF; Gruber D; Papavassiliou DP; Hsu DT; Sehnert AJ; Chung WK; Mital S
Hum Genet; 2007 Dec; 122(5):515-23. PubMed ID: 17851694
[TBL] [Abstract][Full Text] [Related]
2. Genetic polymorphisms in the renin-angiotensin-aldosterone system associated with expression of left ventricular hypertrophy in hypertrophic cardiomyopathy: a study of five polymorphic genes in a family with a disease causing mutation in the myosin binding protein C gene.
Ortlepp JR; Vosberg HP; Reith S; Ohme F; Mahon NG; Schröder D; Klues HG; Hanrath P; McKenna WJ
Heart; 2002 Mar; 87(3):270-5. PubMed ID: 11847170
[TBL] [Abstract][Full Text] [Related]
3. Gene-specific modifying effects of pro-LVH polymorphisms involving the renin-angiotensin-aldosterone system among 389 unrelated patients with hypertrophic cardiomyopathy.
Perkins MJ; Van Driest SL; Ellsworth EG; Will ML; Gersh BJ; Ommen SR; Ackerman MJ
Eur Heart J; 2005 Nov; 26(22):2457-62. PubMed ID: 16087648
[TBL] [Abstract][Full Text] [Related]
4. The role of renin-angiotensin-aldosterone system polymorphisms in phenotypic expression of MYBPC3-related hypertrophic cardiomyopathy.
Kolder IC; Michels M; Christiaans I; Ten Cate FJ; Majoor-Krakauer D; Danser AH; Lekanne Deprez RH; Tanck M; Wilde AA; Bezzina CR; Dooijes D
Eur J Hum Genet; 2012 Oct; 20(10):1071-7. PubMed ID: 22569109
[TBL] [Abstract][Full Text] [Related]
5. Myocardial fibrosis in patients with symptomatic obstructive hypertrophic cardiomyopathy: correlation with echocardiographic measurements, sarcomeric genotypes, and pro-left ventricular hypertrophy polymorphisms involving the renin-angiotensin-aldosterone system.
Blauwet LA; Ackerman MJ; Edwards WD; Riehle DL; Ommen SR
Cardiovasc Pathol; 2009; 18(5):262-8. PubMed ID: 18835191
[TBL] [Abstract][Full Text] [Related]
6. Lack of association among five genetic polymorphisms of the renin-angiotensin system and cardiac hypertrophy in patients with aortic stenosis.
Ortlepp JR; Breithardt O; Ohme F; Hanrath P; Hoffmann R
Am Heart J; 2001 Apr; 141(4):671-6. PubMed ID: 11275936
[TBL] [Abstract][Full Text] [Related]
7. Role of candidate modifier genes on the phenotypic expression of hypertrophy in patients with hypertrophic cardiomyopathy.
Brugada R; Kelsey W; Lechin M; Zhao G; Yu QT; Zoghbi W; Quinones M; Elstein E; Omran A; Rakowski H; Wigle D; Liew CC; Sole M; Roberts R; Marian AJ
J Investig Med; 1997 Dec; 45(9):542-51. PubMed ID: 9444881
[TBL] [Abstract][Full Text] [Related]
8. [Analysis of morpho-functional parameters of the heart and polymorphisms of Renin-Angiotensin-aldosterone system genes in patients with different variants of the course of hypertrophic cardiomyopathy].
Belenkov YN; Privalova EV; Kaplunova VY; Stambol'skiĭ DV; Fomin AA
Kardiologiia; 2010; 50(6):27-34. PubMed ID: 20659024
[TBL] [Abstract][Full Text] [Related]
9. Variants of trophic factors and expression of cardiac hypertrophy in patients with hypertrophic cardiomyopathy.
Patel R; Lim DS; Reddy D; Nagueh SF; Lutucuta S; Sole MJ; Zoghbi WA; Quiñones MA; Roberts R; Marian AJ
J Mol Cell Cardiol; 2000 Dec; 32(12):2369-77. PubMed ID: 11113012
[TBL] [Abstract][Full Text] [Related]
10. Angiotensin-I converting enzyme genotypes and left ventricular hypertrophy in patients with hypertrophic cardiomyopathy.
Lechin M; Quiñones MA; Omran A; Hill R; Yu QT; Rakowski H; Wigle D; Liew CC; Sole M; Roberts R
Circulation; 1995 Oct; 92(7):1808-12. PubMed ID: 7671365
[TBL] [Abstract][Full Text] [Related]
11. Diastolic abnormalities as the first feature of hypertrophic cardiomyopathy in Dutch myosin-binding protein C founder mutations.
Michels M; Soliman OI; Kofflard MJ; Hoedemaekers YM; Dooijes D; Majoor-Krakauer D; ten Cate FJ
JACC Cardiovasc Imaging; 2009 Jan; 2(1):58-64. PubMed ID: 19356534
[TBL] [Abstract][Full Text] [Related]
12. Genetic polymorphism of the renin-angiotensin system and organ damage in essential hypertension.
Pontremoli R; Ravera M; Viazzi F; Nicolella C; Berruti V; Leoncini G; Giacopelli F; Bezante GP; Sacchi G; Ravazzolo R; Deferrari G
Kidney Int; 2000 Feb; 57(2):561-9. PubMed ID: 10652033
[TBL] [Abstract][Full Text] [Related]
13. Impact of renin-angiotensin system polymorphisms on development of systolic dysfunction in hypertrophic cardiomyopathy. Evidence from a study of genotyped patients.
Funada A; Konno T; Fujino N; Muramoto A; Hayashi K; Tsubokawa T; Sakata K; Kawashiri MA; Takeda Y; Ino H; Yamagishi M
Circ J; 2010 Nov; 74(12):2674-80. PubMed ID: 20975235
[TBL] [Abstract][Full Text] [Related]
14. [Renin-angiotensin-aldosterone system in hypertrophic cardiomyopathy].
Kozhevnikova MV; Kaplunova VIu; Privalova EV; Khabarova NV; Belenkov IuN
Kardiologiia; 2014; 54(3):23-8. PubMed ID: 25102745
[TBL] [Abstract][Full Text] [Related]
15. Genetic background of left ventricular hypertrophy in Uzbek hypertensive men.
Kurbanova D; Eliseyeva M
Turk Kardiyol Dern Ars; 2010 Oct; 38(7):466-72. PubMed ID: 21206199
[TBL] [Abstract][Full Text] [Related]
16. [The effect of polymorphisms of the angiotensin-converting enzyme and angiotensinogen genes on the phenotypic expression of Spanish patients with hypertrophic cardiomyopathy].
López-Haldón J; García-Lozano JR; Martínez Martínez A; Núñez-Roldán A; Burgos Cornejo J
Med Clin (Barc); 1999 Jul; 113(5):161-3. PubMed ID: 10480137
[TBL] [Abstract][Full Text] [Related]
17. Distinguishing left ventricular hypertrophy from hypertrophic cardiomyopathy in adolescents: a longitudinal observation study.
Forså MI; Smedsrud MK; Haugaa KH; Bjerring AW; Früh A; Sarvari SI; Landgraff HW; Hallén J; Edvardsen T
Eur J Prev Cardiol; 2024 Mar; 31(5):591-598. PubMed ID: 37992187
[TBL] [Abstract][Full Text] [Related]
18. AT1 receptor A/C1166 polymorphism contributes to cardiac hypertrophy in subjects with hypertrophic cardiomyopathy.
Osterop AP; Kofflard MJ; Sandkuijl LA; ten Cate FJ; Krams R; Schalekamp MA; Danser AH
Hypertension; 1998 Nov; 32(5):825-30. PubMed ID: 9822439
[TBL] [Abstract][Full Text] [Related]
19. Association of angiotensin-converting enzyme activity and polymorphism with echocardiographic measures in familial and nonfamilial hypertrophic cardiomyopathy.
Buck PC; Fernandes F; Arteaga E; Matsumoto AY; Araujo AQ; Oliveira EM; Ianni BM; Ramires FJ; Krieger JE; Mady C
Braz J Med Biol Res; 2009 Aug; 42(8):717-21. PubMed ID: 19390744
[TBL] [Abstract][Full Text] [Related]
20. ACE and AGTR1 polymorphisms and left ventricular hypertrophy in endurance athletes.
Di Mauro M; Izzicupo P; Santarelli F; Falone S; Pennelli A; Amicarelli F; Calafiore AM; Di Baldassarre A; Gallina S
Med Sci Sports Exerc; 2010 May; 42(5):915-21. PubMed ID: 19997001
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
